Single platelet inhibitor or less | Warfarin | DAPT | DOAC | |||
Number of operations | n | 107 | 8 | 13 | 5 | |
PO length of stay | days | 4 (2) | 4.5 (3) | 7 (7) | 3 (1) | |
PO ICU stay | days | 2 (3) | 2.5 (1.75) | 2 (4.5) | 1 (3) | |
PO ventilator >24 hour | % | 23 | 25 | 23 | 50 | |
PO reintubated | % | 6 | 0 | 0 | 20 | |
PO renal replacement therapy | % | 4 | 0 | 15 | 0 | |
PO circulatory support | % | 0 | 0 | 8 | 0 | |
PO bleeding | ml | 660 (990) | 615 (550) | 820 (870) | 820 (3246) | |
Any transfusion | % | 96 | 100 | 92 | 100 | |
erythrocytes | units | 3 (4.75) | 2 (2) | 5 (4) | 19 (21) | |
plasma | units | 5 (5.75) | 2.5 (3.25) | 5 (4) | 12 (20) | * DOAC vs warfarin |
thrombocytes | units | 1 (1) | 1 (1.25) | 1 (3) | 4 (6) | |
PO autotransfusion | % | 32 | 38 | 15 | 75 | |
PO autotransfusion | ml | 0 (450) | 0 (518) | 0 (0) | 591 (521) | |
PO nitrous oxide | % | 0 | 0 | 0 | 0 | |
PO pulmonary artery catheter | % | 0 | 0 | 0 | 20 | * |
PO superficial infection | % | 1 | 0 | 0 | 0 | |
PO pneumonia | % | 9 | 12 | 15 | 20 | |
PO other infection | % | 4 | 12 | 0 | 0 | |
PO mediastinitis | % | 1 | 0 | 0 | 0 | |
PO inotropic support | % | 10 | 38 | 42 | 20 | * |
PO sternal dehiscence | % | 0 | 0 | 0 | 0 | |
PO revision for bleeding | % | 9 | 12 | 15 | 60 | * |
PO CPR | % | 4 | 12 | 0 | 0 | |
PO septicaemia | % | 1 | 0 | 8 | 0 | |
PO arrhythmia | % | 24 | 50 | 33 | 40 | |
PO pacemaker >24 hour | % | 4 | 0 | 8 | 0 | |
PO new chest tube | % | 2 | 12 | 0 | 25 | * |
PO myocardial infarction | % | 1 | 0 | 0 | 0 | |
PO stroke | % | 9 | 25 | 15 | 0 | |
PO paraparesis | % | 4 | 0 | 8 | 0 | |
PO other reoperation | % | 5 | 0 | 38 | 20 | * |
PO failure in other organs | % | 8 | 0 | 15 | 0 | |
PO delayed cardiac tamponade | % | 3 | 12 | 8 | 40 | * |
PO return to ICU | % | 7 | 0 | 0 | 0 | |
PO pressure ulcer | % | 0 | 0 | 0 | 0 | |
PO mobilised <24 hour | % | 70 | 50 | 54 | 40 | |
n | 108 | 8 | 13 | 6 | ||
PO in-department mortality | % | 2 | 25 | 8 | 33 | * |
30 days mortality | % | 8 | 25 | 8 | 67 | * |
*p<0.05
CPR, Cardiopulmonary resuscitation; DAPT, dual anti-platelet inhibitors; DOAC, direct oral anticoagulants ; ICU, intensive care unit; PO, postoperative.